Gallbladder Cancer Clinical Trials

119 clinical trials for Gallbladder Cancer across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Integrated Cancer Repository for Cancer Research — RECRUITING
• Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer — RECRUITING · PHASE1
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
• Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer — RECRUITING · PHASE2
• EULAT Eradicate GBC — RECRUITING
• STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy — RECRUITING · NA
• Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) — RECRUITING · PHASE2
• NGS in Gallbladder Cancer and Response to Treatment — RECRUITING
• Addition of Everolimus to Standard of Care in Carcinoma Gallbladder — RECRUITING · PHASE2
• The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer — RECRUITING · NA
• The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer — RECRUITING
• Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer — RECRUITING · PHASE2
• Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer — RECRUITING
• A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors — TERMINATED · PHASE2
• The PLATON Network — TERMINATED
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer — ACTIVE_NOT_RECRUITING · NA
• Biomarker Discovery in Patients With Advanced Biliary Tract Cancer — COMPLETED
• Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer — COMPLETED
• Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer — TERMINATED
• To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Predicting Incidental Gallbladder Cancer — ACTIVE_NOT_RECRUITING
• Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors — TERMINATED · PHASE2
• PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) — COMPLETED · NA
• Global Evaluation of Cholecystectomy Knowledge and Outcomes — COMPLETED
• Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Proteomic Analysis of Patients Undergoing Bariatric Surgery — NOT_YET_RECRUITING · NA
• Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms — COMPLETED · NA
• Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Quebec Pancreas Cancer Study — OTHER
• Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer — NOT_YET_RECRUITING
• UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-up — ACTIVE_NOT_RECRUITING
• Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer — COMPLETED
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer — COMPLETED · PHASE1
• Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer — OTHER · PHASE2
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — TERMINATED · PHASE2
• Pembrolizumab in Biliary Tract Cancer — COMPLETED · PHASE2
• M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) — COMPLETED · PHASE2
• Behavioral Weight Loss Program for Cancer Survivors in Maryland — COMPLETED · NA
• Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer — OTHER
• Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC — OTHER · PHASE2
• Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer — TERMINATED · PHASE3
• Hepatobiliary Tumors Tissue Samples Acquisition — OTHER
• The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases — NOT_YET_RECRUITING
• ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers — COMPLETED · PHASE1
• Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer — OTHER
• A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up — OTHER
• Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer — OTHER
• Programs To Support You During Chemotherapy — COMPLETED · NA
• Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report — COMPLETED

Refine this search